Most retail investors on NEPSE read an insurer the way they read a bank, or worse, a sugar mill. They look at premium income the way they would look at a bank’s loan book or a factory’s sales, see it rising, and decide the company is doing well. That instinct is wrong, and it costs people money. To analyze an insurance stock on NEPSE properly, you have to understand that an insurer earns money in two separate places, and a company can be winning loudly in one while quietly losing in the other.
An insurer is not a sales business. It is a promise business. It collects premiums today against claims it may have to pay years from now, and the gap between those two events is where both the profit and the danger live. Premium growth tells you almost nothing on its own. A company can double its premiums in two years by underpricing policies that will blow up later. The numbers that actually matter are the claims ratio, the expense ratio, the combined ratio, the technical reserves, the solvency margin, and what the company earns on its float. This piece walks through each one, what good and weak look like, and why the fastest-growing insurer on the board can still be the worst business on it.
First, know who is watching the watchmen
Before any ratio, understand the regulator, because insurance is the most heavily supervised corner of NEPSE. Insurers are governed by the Nepal Insurance Authority (NIA, or Nepal Beema Pradhikaran), the body that replaced the old Insurance Board (Beema Samiti) after the Insurance Act, 2079 (2022) came into force. The NIA began operating in its current form on November 8, 2022 (Nepal Insurance Authority / Wikipedia).
The NIA does the things that make insurance different from any other listed sector. It sets minimum paid-up capital. It dictates how much of the float an insurer may invest and where. It enforces a solvency framework. And it can stop a weak insurer from paying dividends until its balance sheet recovers. Following the 2022 Act, the authority raised minimum paid-up capital sharply, and it has issued a new Risk-Based Capital (RBC) and Solvency directive that ties required capital to the actual risk an insurer carries rather than a flat number (Beema Post). That shift, phased in over the coming years, is the single biggest structural change to how you should value these stocks. We will come back to it.
One more split you cannot skip. Life insurers and non-life (general) insurers are different businesses with different economics, and you must never compare them on the same ratios. Life insurers collect premiums over decades and sit on enormous, slow-moving reserves. Non-life insurers (motor, property, marine, health, engineering) write one-year policies and pay claims fast. The float is huge and long for life, smaller and faster for non-life. A life insurer’s value lives mostly in its reserves and investment book. A non-life insurer’s value lives mostly in its underwriting discipline. Judge each on its own terms.
The claims ratio: how much of every rupee goes back out
Start here, because this is the heart of underwriting. The claims ratio, also called the loss ratio, is the share of premiums an insurer pays back out as claims.
Claims ratio = claims incurred ÷ net premiums earned.
If a non-life insurer collects NPR 100 crore in premiums and pays NPR 60 crore in claims, its claims ratio is 60 percent. That 60 paisa on the rupee is the raw cost of the insurance it sold. A low, stable claims ratio means the company priced its risk well and is not buying business by writing cheap, dangerous policies. A high or rising claims ratio means either the underwriting is sloppy, the pricing is too soft, or a bad year (floods, earthquakes, a spike in motor accidents) has hit.
Watch the trend, not the single year. One bad monsoon can spike a non-life insurer’s claims ratio without telling you anything about management quality. A claims ratio that climbs three years running while the company brags about premium growth is the clearest warning sign there is. It usually means the company bought its growth by underpricing.
The expense ratio and the combined ratio: the number that decides everything
The claims ratio is only half the cost. Running an insurer also costs money: agent commissions, salaries, marketing, administration. That is the expense ratio.
Expense ratio = operating and acquisition expenses ÷ net premiums earned.
Now add the two together, and you get the single most important number for a non-life insurer, the combined ratio.
Combined ratio = claims ratio + expense ratio.
This one number tells you whether the insurer makes or loses money on the actual business of insurance before it earns a single rupee from investments. The logic is brutally simple:
- Combined ratio below 100 percent means the insurer is making an underwriting profit. It is being paid to hold other people’s money.
- Combined ratio above 100 percent means the insurer is making an underwriting loss. It is paying, through claims and costs, more than it collects in premiums. It is effectively paying for the privilege of holding the float.
Here is the take that NEPSE investors most need to hear. A combined ratio above 100 is not automatically fatal, because the insurer can still come out ahead on investment income. But it is a flashing red light, and a fast-growing insurer with a combined ratio above 100 is usually destroying value, not creating it. Growth that comes from writing policies that lose money on underwriting just means the company is losing money faster. Premium growth and a combined ratio above 100 together are not a success story. They are a warning that the company is buying market share with mispriced risk and hoping its investment book bails it out.
When you read a quarterly report, this is the discipline that separates a real business from a balloon. The same care you would apply to a bank, where you look past headline profit to asset quality, applies here. (If you want the banking version of this exercise, see how to read a bank’s quarterly report and which banking ratios actually matter.)
Technical reserves: the promise on the balance sheet
An insurer’s biggest liability is not a loan. It is the money it has set aside to pay claims it knows are coming or suspects are coming. These are the technical reserves, also called technical provisions. They include reserves for claims already reported but not yet paid, reserves for claims that have happened but have not yet been reported, and, for life insurers, the mathematical reserves that back decades of future policy payouts.
Reserves are where the honesty of an insurer is tested. An insurer that under-reserves, that sets aside too little, will look more profitable than it really is because money that should sit as a liability instead flows through as profit. That flatters earnings now and detonates later when the claims actually arrive. You cannot fully audit reserve adequacy from the outside, but you can watch for tells: a company whose reserves are not keeping pace with premium growth or whose profits jump while peers’ do not deserves suspicion rather than applause. For a life insurer, especially, the reserve is the business. Treat large, steadily growing technical reserves backed by a conservative investment book as a sign of strength, not as dead weight.
The solvency margin: can it survive a bad year
The solvency margin answers the only question that ultimately matters for a promise business: if claims come in worse than expected, does the company have enough capital to pay them? It is, in plain terms, the cushion of assets an insurer holds over and above its liabilities.
Solvency ratio = admissible assets ÷ required solvency liabilities (broadly, available capital against required capital).
The NIA sets a minimum. Reporting indicates the regulatory benchmark has been a solvency ratio of 1.5, and audited insurers have generally cleared it, with the non-life sector’s average solvency ratio reported around 2.67 in a recent period (Beema Post). A ratio of 1.5 means the company holds one and a half times the capital it is required to hold. Comfortably above the minimum is what you want. Right at the line, or only kept above it by aggressive accounting, is a company one bad year away from regulatory trouble, including a ban on paying dividends.
This is where the bigger regulatory shift bites. The new Risk-Based Capital and Solvency directive ties required capital to the actual risk an insurer runs, so an insurer holding riskier assets or writing riskier policies will need more capital than one playing it safe (Beema Post). Under this regime, two insurers with the same paid-up capital can have very different real solvency. As an investor, you should start asking not just whether an insurer clears the old flat threshold but how much capital its risk profile actually demands.
The float: where the real money often hides
Now the part that NEPSE coverage almost never explains. Between the moment an insurer collects a premium and the moment it pays a claim, it holds a large pool of cash that belongs, in effect, to policyholders but sits in the company’s hands. This is the float. The insurer invests it, in fixed deposits, government bonds, and equities within the limits the NIA allows, and keeps the investment income.
Warren Buffett built Berkshire Hathaway largely on this idea: the float is money the company holds but does not own, and if underwriting at least breaks even, that money is effectively a free loan the insurer gets paid to use (FinMasters). For many insurers, investment income on the float is not a side dish. It is the main course. This is doubly true for life insurers in Nepal, whose float is enormous and long-dated, which is why a life insurer’s investment yield and asset mix matter as much as its underwriting.
But float is only an asset if it is good float. Two questions decide that. First, how was the float acquired? Float that comes from disciplined underwriting (combined ratio at or below 100) is genuinely free money. Float bought through an underwriting loss is expensive money, because the insurer is paying for it through claims and costs. Second, how is the float invested? An insurer earning steady returns on bonds and deposits is on solid ground. One reaching for yield by overweighting equities into a hot market is taking on risk that does not show up in the premium numbers at all. Given how concentrated the NEPSE market is, an insurer’s investment book can swing its profits hard in both directions.
Putting it together: the verdict
So how do you actually analyze an insurance stock on NEPSE? Stop leading with premium growth. Premium growth is the headline incumbents love and the metric that misleads retail investors most. Read the company in this order instead: claims ratio (is the underwriting sound and stable?); combined ratio (does it make money on insurance at all, and is it under 100?); reserves (is it being honest about future claims?); solvency margin (can it survive a bad year, and how does its risk profile look under the new RBC regime?); and finally the float (how was it earned, and how is it invested?).
The verdict is this. Judge a Nepali insurer on underwriting discipline and float quality, not on premium growth. A slower-growing insurer with a combined ratio in the low 90s, conservative reserves, a fat solvency cushion, and a sensibly invested float is a far better business than a fast-growing rival running a combined ratio above 100 and chasing equity returns to cover the gap. Growth bought with underpriced policies does not build value. It postpones a loss. The market often takes years to figure out which insurer is which, which is exactly why doing this analysis yourself, before the crowd, is where the edge is.
If you are weighing an insurer against other parts of your portfolio, the same framework-first discipline applies to other under-analyzed sectors, such as how to value a hydropower stock on NEPSE, and it helps to keep paid-up capital and market cap straight when an insurer announces a rights issue.
This is analysis, not financial advice.
